These notably include MYC, an oncogenic transcription factor with a pivotal role in breast cancer progression (Liao and Dickson 2000) and whose amplification and overexpression is a marker of aggressive and invasive breast cancer (Corzo et al. 2006; Berns et al. 1992). This evidence concerns the gene MYC and breast carcinoma.